Dystonia.
Dystonia has moved from the status of a rare disease or an uncommon clinical manifestation to the center stage of research in movement disorders. Recent developments have expanded our knowledge of the genetics and understanding of its pathophysiology, and have resulted in significant improvements in the clinical management of this group of disorders. These, as well as the varied and multifaceted phenomenology are reviewed.
Sackler Faculty of Medicine, Tel Aviv University, Israel.
A D
AD
Korczyn
R
R
Inzelberg
D000818:Animals; D001479:Basal Ganglia / Q000503:physiopathology; D002874:Chromosome Mapping; D002899:Chromosomes, Human, Pair 9; D004409:Dyskinesia, Drug-Induced / Q000235:genetics / Q000503:physiopathology*; D004421:Dystonia / Q000235:genetics / Q000503:physiopathology*; D004422:Dystonia Musculorum Deformans / Q000235:genetics / Q000503:physiopathology; D008040:Genetic Linkage; D006801:Humans; D009460:Neurologic Examination